Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 41
Exploring Horizons for Domestic Animal Genomics: Workshop Summary Appendix C Workshop Speaker Biographies ERIC GREEN, is Senior Investigator and Chief, Genome Technology Branch, and Director, Intramural Sequencing Center, of the National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI). Dr. Green’s laboratory focuses on the mapping and sequencing of eukaryotic genomes and the development of efficient approaches for utilizing the resulting information to study important biologic problems. One of his major projects currently involves mapping and sequencing genomic regions orthologous to human chromosome 7 in other animals, initially in mouse but more recently in other distantly related vertebrates. This project is being performed in close collaboration with the NIH Intramural Sequencing Center. Dr. Green’s Laboratory also is interested in identifying and characterizing genes associated with human disease such as those associated with hereditary deafness (Pendred syndrome), cancer, neurologic disease, mental disorders, vascular disease, and others. He received M.D. and Ph.D. degrees from Washington University, St. Louis. RICHARD GIBBS, is Director of the Human Genome Sequencing Center, and Professor, in the Department of Molecular and Human Genetics, at the Baylor College of Medicine. Dr. Gibbs’ current focus is on producing a draft sequence of the rat genome, in collaboration with Celera Genomics Corporation and Genome Therapeutics Corporation. He received a B.Sc. (Hons) in 1979 and a Ph.D. in genetics and radiation biology in 1986 at the University of Melbourne, Melbourne, Australia. He moved to Houston as a postdoctoral fellow at the Baylor College of Medicine to examine the molecular basis of human-linked diseases, and to develop technologies used for rapid genetic analysis. In 2000, Dr. Gibbs received the annual Michael E. DeBakey, M.D., Excellence in Research Award.
OCR for page 42
Exploring Horizons for Domestic Animal Genomics: Workshop Summary STEVEN KAPPES, is Center Director of the Roman L. Hruska U.S. Meat Animal Research Center (MARC) of the U.S. Department of Agriculture-Agricultural Research Service (ARS), in Clay Center, Nebraska. Before receiving his Ph.D. in Animal Science (Molecular Biology and Reproduction) from the University of Missouri-Columbia in 1992, he worked for ARS at MARC for six years as a Cattle Operations Assistant Manager. After earning his Ph.D., Dr. Kappes started his professional career at MARC as a Research Physiologist. In 1999, he joined the ARS Animal Production, Product Value, and Safety unit of the National Program Staff in Beltsville, Maryland. HARRIS LEWIN, is a Professor in the Department of Animal Sciences at the University of Illinois, Urbana-Champaign. Dr. Lewin’s laboratory currently is focusing on three research areas, including the molecular characterization of the bovine major histocompatibility complex (MHC), the genetic and immunologic mechanisms of resistance and susceptibility to bovine leukemia virus (BLV) infection and disease progression, and gene mapping in cattle, with an emphasis on comparative mapping and mapping genes controlling economically important traits. Over the past five years his laboratory has developed a 300 marker linkage map of the bovine genome. Presently, Dr. Lewin and his colleagues are beginning to expand the map, with “expressed sequence tags,” or ESTs. STEPHEN O’BRIEN, is Chief of the Laboratory of Genomic Diversity and head of the Section of Genetics at the National Cancer Institute (NCI). Dr. O’Brien came to National Institutes of Health as a postdoctoral fellow and designed a program based on mammalian somatic cell genetics. He is co-Chair of the International Committee on Comparative Gene Mapping and Editor of Genetic Maps. The central focus of Dr. O’Brien’s laboratory research concerns the collaborative interaction of mammalian cellular genes operative in concordant evolutionary descent of the immune system, retroviruses, and cancer onset. The purpose of these investigations is to determine the comparative mammalian genetic principles that participate in these processes. ROGER WYSE, is Managing Director of Burrill & Company, which sponsors and manages a family of venture capital funds. Dr. Wyse has more than 27 years of experience as an internationally recognized scientist and was previously an administrator at Rutgers University and the University of Wisconsin, Madison, where he was Dean of the College of Agricultural and Life Sciences. Dr. Wyse received a Ph.D. in plant physiology from Michigan State University and a B.S. in agronomy from The Ohio State University. He served as co-CEO of Third Wave AgBio, which offers animal and plant genetics assays, was founding President and CEO of AniGenics, a fully integrated animal genomics company, and serves on the Boards of Directors of AniGenics and E-Markets.
Representative terms from entire chapter: